Profil
John Connelly worked as Vice President-Program & Alliance Management at Voyager Therapeutics, Inc. from 2015 to 2018.
He also worked as Chief Development Officer at Akouos, Inc. Mr. Connelly holds an MBA from Suffolk University and an undergraduate degree from the University of Vermont.
Ehemalige bekannte Positionen von John Connelly
| Unternehmen | Position | Ende |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Corporate Officer/Principal | 01.02.2018 |
| AKOUOS | Corporate Officer/Principal | - |
Ausbildung von John Connelly
| Suffolk University | Masters Business Admin |
| University of Vermont | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
